Search -

Displaying 41 - 54 of 54

Sort: Relevancy | Date

Presentation TCT 2015

Fifteen-Year DEFER and 5-Year FAME Outcomes

Presenter: Allen Jeremias, Nils Johnson, Nico H.J. Pijls

October 12, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

Presentation

Prognostic Value of FFR: Linking PhysiologicSeverity to Clinical Outcomes

Presenter: Nils P. Johnson

October 16, 2014

Presentation TCT 2014

Role of Intravascular Imaging in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Fernando Alfonso

September 16, 2014

Presentation TCT 2014

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Colin Berry

September 16, 2014

Presentation Physiology and Intravascular Imaging 2014

PRO: Hyperemia Adds Significantly to Detection of Ischemia and Is Essential for Accurate Physiological Lesion Assessment

Presenter: Nils P. Johnson

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Case Studies: FFR Artifacts

Presenter: Nils P. Johnson

March 27, 2014

Presentation TCT 2013

What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

PET and Fusion PET-CT: Potential Role for Metabolic Imaging of Vulnerable Plaque

Presenter: Nils Johnson

October 30, 2013

Presentation TCT 2013

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

Presenter: Nils P. Johnson

October 29, 2013

Presentation TCT 2013

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Presenter: Nils Johnson

October 29, 2013

Presentation PCI Outcomes 2013

Optimizing PCI Outcomes: FFR meets PET

Presenter: Nils P. Johnson

March 07, 2013

Presentation TCT 2012

Correlation Between FFR and iFR: An Independent Validation Study

Presenter: Nils Johnson

October 25, 2012

Advertisement

Fifteen-Year DEFER and 5-Year FAME Outcomes

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Prognostic Value of FFR: Linking PhysiologicSeverity to Clinical Outcomes

Role of Intravascular Imaging in NSTE-ACS and STEMI

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

PRO: Hyperemia Adds Significantly to Detection of Ischemia and Is Essential for Accurate Physiological Lesion Assessment

Case Studies: FFR Artifacts

What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)?

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

PET and Fusion PET-CT: Potential Role for Metabolic Imaging of Vulnerable Plaque

What would an outcomes trial comparing FFR for all lesions versus a hybrid approach (resting index plus selective FFR) look like?

TCT-80. Applicability of hybrid strategy (resting index plus selective FFR) to assess hemodynamic significance of coronary stenoses depends on FFR distribution

Optimizing PCI Outcomes: FFR meets PET

Correlation Between FFR and iFR: An Independent Validation Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content